SWOG clinical trial number
S0501
Nonmyeloablative Allogeneic Stem Cell Transplantation for Relapsed Hodgkin's or Non-Hodgkin's Lymphoma After Autologous Transplantation (A BMT Study)
2% Accrual
Accrual
2%
Closed
Phase
2% Accrual
Accrual
2%
Abbreviated Title
HODGKIN'S/NON-HODGKIN'S: Nonmyeloablative Allogeneic Stem Cell Transplantation
Activated
07/01/2005
Closed
01/10/2007
Participants
Limited Institutions: Allogeneic BMT Members
Research committees
Lymphoma
Treatment
Filgrastim
Fludarabine Phosphate
Melphalan
Methotrexate
Tacrolimus
Eligibility Criteria Expand/Collapse
Other Clinical Trials
S2308
SWOG Clinical Trial Number
Research Committee(s)
Lymphoma
Activated
08/01/2024
21% Accrual
Accrual
21%
Open
Phase
S2207
SWOG Clinical Trial Number
Research Committee(s)
Lymphoma
Activated
06/30/2023
12% Accrual
Accrual
12%
Open
Phase
CTSU/AHOD2131
SWOG Clinical Trial Number
Research Committee(s)
Lymphoma
Immunomolecular Therapeutics
Activated
04/28/2023
Open
Phase